First Data Corporation in its $760 million acquisition of BluePay, Inc.in its pending sale to Chicken Soup for the Soul Entertainment, Inc. Deluxe Corporation in its $960 million acquisition of First American Payment Systems, L.P.and its up to $1.225 billion acquisition of Amunix Pharmaceuticals, Inc. Sanofi in its $4.8 billion acquisition of Ablynx NV its $3.2 billion acquisition of Translate Bio, Inc.in its $2.2 billion merger with Cintas Corporation. III, a SPAC sponsored by Spartan Acquisition Sponsor III LLC (an affiliate of Apollo Global Management).
(n/k/a Allego N.V.) (a portfolio company of Meridiam Infrastructure Partners) in its $3.14 billion business combination with Spartan Acquisition Corp. in Skillz's business combination with Flying Eagle Acquisition Corp., a SPAC, in a transaction that implied an equity valuation for Skillz of $3.5 billion.
Principal shareholders and directors of Skillz Inc. and Radiopharmaceuticals its sale of veterinary assets to Virbac SA and its strategic review of Elanco, its animal health division, concluding with the initial public offering of a minority stake in Elanco. its acquisitions of CoLucid Pharmaceuticals, Inc., ChemGen Corp. its $1 billion acquisition of Prevail Therapeutics Inc. its $5.4 billion acquisition of the animal health business of Novartis its $1.1 billion acquisition of Dermira, Inc. Eli Lilly and Company in its approximately $8 billion acquisition of Loxo Oncology, Inc. (BPY) in BPY's $14.4 billion acquisition of the approximately 66% of common stock that it did not already own of GGP Inc. in its approximately $4.8 billion acquisition of a 61.2% stake in Oaktree Capital Group, LLC. in its $6.2 billion sale to Telefonaktiebolaget LM Ericsson. Foley II, in a $9 billion business combination with Paysafe Limited. II, a SPAC sponsored by an affiliate of Trasimene Capital Management, LLC and led by William P. that has an enterprise value based on the transaction of approximately $11 billion. Churchill Capital Corp III, a SPAC sponsored by Churchill Capital Group, in its $5.7 billion merger with MultiPlan, Inc. Churchill Capital Corp IV, a SPAC sponsored by Churchill Capital Group, in its $11.75 billion take-public merger with Lucid Motors. Willis Group Holdings plc in its $18 billion merger of equals with Towers Watson & Co. JAB Holding Company, as leader of an investment group, in that group's $13.9 billion take-private of Keurig Green Mountain, Inc. in its $17.6 billion all-stock merger of equals with Quintiles Transnational Holdings Inc. (BAT) of the 57.8% of Reynolds stock that BAT did not already own. in Reynolds’ $60.6 billion sale to British American Tobacco p.l.c. Transaction Committee of the Board of Directors of Reynolds American Inc. Willis Towers Watson PLC in its proposed $80 billion combination with Aon PLC. Matthew also counsels clients on a broad range of corporate, securities and business-related matters, including fiduciary duties, corporate governance, disclosure issues and compliance matters, as well as defensive measures, takeover tactics, proxy fights and other contests for corporate control. Matthew regularly represents acquirors, targets, boards of directors, special committees, investment banks and investors in complex domestic and cross border M&A (both negotiated and unsolicited) in a broad range of industries, including for clients such as: Eli Lilly and Company The Kroger Company Jefferies Financial Group Sanofi Willis Towers Watson Brookfield JPMorgan and Centerview Partners.
0 kommentar(er)
